NCT04770285View on ClinicalTrials.gov

Trial to Evaluate the Effectiveness of a Digital Therapeutics in Adults Diagnosed With Major Depressive Disorder

NACompletedINTERVENTIONAL
Enrollment

386

Participants

Timeline

Start Date

February 25, 2021

Primary Completion Date

October 26, 2022

Study Completion Date

October 26, 2022

Conditions
Major Depressive Disorder
Interventions
DEVICE

CT-152 - Digital Therapeutic

CT-152 mobile app was used by the participants as per the schedule specified in the respective arm.

DEVICE

Sham

Sham mobile app was used by the participants as per the schedule specified in the respective arm.

Trial Locations (1)

75231

For additional information regarding sites, contact 844-687-8522, Dallas

Sponsors

Collaborators (1)

Click Therapeutics, Inc.
All Listed Sponsors
collaborator

Click Therapeutics, Inc.

INDUSTRY

lead

Otsuka Pharmaceutical Development & Commercialization, Inc.

INDUSTRY

NCT04770285 - Trial to Evaluate the Effectiveness of a Digital Therapeutics in Adults Diagnosed With Major Depressive Disorder | Biotech Hunter | Biotech Hunter